Structure of mammalian AMPK and its regulation by ADP-Reference-Cited by-同舟云学术

Structure of mammalian AMPK and its regulation by ADP

Published:2011-03-13 Issue:7342 Volume:472 Page:230-233
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Xiao Bing,Sanders Matthew J.,Underwood Elizabeth,Heath Richard,Mayer Faith V.,Carmena David,Jing Chun,Walker Philip A.,Eccleston John F.,Haire Lesley F.,Saiu Peter,Howell Steven A.,Aasland Rein,Martin Stephen R.,Carling David,Gamblin Steven J.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature09932.pdf

Reference30 articles.

1. Carling, D. The AMP-activated protein kinase cascade–a unifying system for energy control. Trends Biochem. Sci. 29, 18–24 (2004)

2. Hardie, D. G. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nature Rev. Mol. Cell Biol. 8, 774–785 (2007)

3. Kahn, B. B., Alquier, T., Carling, D. & Hardie, D. G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1, 15–25 (2005)

4. Shackelford, D. B. & Shaw, R. J. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nature Rev. Cancer 9, 563–575 (2009)

5. Cool, B. et al. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab. 3, 403–416 (2006)

Cited by 747 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperglycemia-driven signaling bridges between diabetes and cancer;Biochemical Pharmacology;2024-11

2. The pro-drug C13 activates AMPK by two distinct mechanisms;Biochemical Journal;2024-09-12

3. 8-Prenylgenistein Isoflavone in Cheonggukjang Acts as a Novel AMPK Activator Attenuating Hepatic Steatosis by Enhancing the SIRT1-Mediated Pathway;International Journal of Molecular Sciences;2024-09-08

4. AMPK, a hub for the microenvironmental regulation of bone homeostasis and diseases;Journal of Cellular Physiology;2024-08-30

5. The human AMPKγ3 R225W mutation negatively impacts site‐1 nucleotide binding and does not enhance basal AMPKγ3‐associated activity nor glycogen production in human or mouse skeletal muscle;Acta Physiologica;2024-08-22